ABIOMED INC (ABMD) Stock Price, Forecast & Analysis
NASDAQ:ABMD • US0036541003
ABMD Key Statistics, Chart & Performance
The current stock price of ABMD is 381.02 USD. In the past month the price increased by 0.8%. In the past year, price increased by 8.18%.
ABMD Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to ABMD. When comparing the yearly performance of all stocks, ABMD is one of the better performing stocks in the market, outperforming 96.07% of all stocks.
ABMD Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to ABMD. ABMD is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.
ABMD Financial Highlights
Over the last trailing twelve months ABMD reported a non-GAAP Earnings per Share(EPS) of 4.84. The EPS decreased by -3.78% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 24.84% | ||
| ROA | 15.72% | ||
| ROE | 17.32% | ||
| Debt/Equity | 0 |
ABMD Forecast & Estimates
16 analysts have analysed ABMD and the average price target is 375.36 USD. This implies a price decrease of -1.49% is expected in the next year compared to the current price of 381.02.
For the next year, analysts expect an EPS growth of 3.83% and a revenue growth 10.29% for ABMD
ABMD Ownership
ABMD Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.94 | 195.119B | ||
| ISRG | INTUITIVE SURGICAL INC | 47.92 | 179.003B | ||
| SYK | STRYKER CORP | 25.39 | 145.408B | ||
| BSX | BOSTON SCIENTIFIC CORP | 21.35 | 110.604B | ||
| BDX | BECTON DICKINSON AND CO | 11.63 | 52.82B | ||
| IDXX | IDEXX LABORATORIES INC | 41.99 | 50.758B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.48 | 46.296B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.65 | 38.388B | ||
| RMD | RESMED INC | 21.3 | 37.749B | ||
| DXCM | DEXCOM INC | 29.39 | 28.503B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About ABMD
Company Profile
ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. The company is headquartered in Danvers, Massachusetts and currently employs 2,003 full-time employees. The firm develops, manufactures and markets its products, which are designed to enable the heart to rest by improving blood flow and/or performing the pumping of the heart. Its products are used in the cardiac catheterization lab or cath lab, by interventional cardiologists and in the heart surgery suite by cardiac surgeons for patients who are in need of hemodynamic support prophylactically or emergently before, during or after angioplasty, or heart surgery procedures. The firm's Impella device portfolio includes the Impella 2.5, Impella CP, Impella 5.0, Impella LD, Impella 5.5 and Impella RP devices. Its product pipeline includes Impella ECP, Impella XR Sheath, Impella BTR and precardiac. The Impella ECP device is designed for blood flow of greater than three and a half liters per minute. The Impella BTR device is designed to be a heart pump with integrated motors and sensors.
Company Info
ABIOMED INC
22 Cherry Hill Dr
Danvers MASSACHUSETTS 01923 US
CEO: Michael R. Minogue
Employees: 2003
Phone: 19787775410.0
ABIOMED INC / ABMD FAQ
What does ABMD do?
ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. The company is headquartered in Danvers, Massachusetts and currently employs 2,003 full-time employees. The firm develops, manufactures and markets its products, which are designed to enable the heart to rest by improving blood flow and/or performing the pumping of the heart. Its products are used in the cardiac catheterization lab or cath lab, by interventional cardiologists and in the heart surgery suite by cardiac surgeons for patients who are in need of hemodynamic support prophylactically or emergently before, during or after angioplasty, or heart surgery procedures. The firm's Impella device portfolio includes the Impella 2.5, Impella CP, Impella 5.0, Impella LD, Impella 5.5 and Impella RP devices. Its product pipeline includes Impella ECP, Impella XR Sheath, Impella BTR and precardiac. The Impella ECP device is designed for blood flow of greater than three and a half liters per minute. The Impella BTR device is designed to be a heart pump with integrated motors and sensors.
What is the stock price of ABIOMED INC today?
The current stock price of ABMD is 381.02 USD. The price increased by 0.06% in the last trading session.
What is the dividend status of ABIOMED INC?
ABMD does not pay a dividend.
What is the ChartMill rating of ABIOMED INC stock?
ABMD has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
What sector and industry does ABIOMED INC belong to?
ABIOMED INC (ABMD) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
How many employees does ABIOMED INC have?
ABIOMED INC (ABMD) currently has 2003 employees.
What is ABIOMED INC worth?
ABIOMED INC (ABMD) has a market capitalization of 17.18B USD. This makes ABMD a Large Cap stock.